Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB SCHA VTWO PRFZ

Index	RUT	P/E	-	EPS (ttm)	-1.83	Insider Own	10.29%	Shs Outstand	301.91M	Perf Week	-6.04%
Market Cap	516.26M	Forward P/E	-	EPS next Y	-0.48	Insider Trans	-0.09%	Shs Float	270.83M	Perf Month	-27.54%
Enterprise Value	939.17M	PEG	-	EPS next Q	-0.15	Inst Own	58.03%	Short Float	13.14%	Perf Quarter	-1.72%
Income	-546.38M	P/S	3.23	EPS this Y	70.97%	Inst Trans	0.81%	Short Ratio	4.49	Perf Half Y	39.02%
Sales	160.00M	P/B	14.30	EPS next Y	8.52%	ROA	-53.45%	Short Interest	35.59M	Perf YTD	-8.56%
Book/sh	0.12	P/C	1.85	EPS next 5Y	38.58%	ROE	-213.45%	52W High	2.73 -37.36%	Perf Year	15.54%
Cash/sh	0.93	P/FCF	-	EPS past 3/5Y	-9.18% -	ROIC	-77.20%	52W Low	0.85 100.92%	Perf 3Y	-83.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.64% 15.19%	Gross Margin	42.75%	Volatility	9.53% 9.42%	Perf 5Y	-96.60%
Dividend TTM	-	EV/Sales	5.87	EPS Y/Y TTM	-61.50%	Oper. Margin	-331.23%	ATR (14)	0.18	Perf 10Y	-80.59%
Dividend Ex-Date	-	Quick Ratio	5.99	Sales Y/Y TTM	3.89%	Profit Margin	-341.47%	RSI (14)	35.83	Recom	2.11
Dividend Gr. 3/5Y	- -	Current Ratio	6.89	EPS Q/Q	71.82%	SMA20	-20.40%	Beta	2.30	Target Price	2.43
Payout	-	Debt/Eq	131.29	Sales Q/Q	13.82%	SMA50	-18.54%	Rel Volume	1.15	Prev Close	1.84
Employees	575	LT Debt/Eq	131.29	Earnings	Feb 12 AMC	SMA200	6.67%	Avg Volume	7.93M	Price	1.71
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.53% 3.74%	Trades		Volume	9,096,669	Change	-7.07%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:30AM	Pacific Biosciences of California, Inc. Q4 2025 Earnings Call Summary (Moby)
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Loading…
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
06:15PM	Loading…
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Loading…
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
Sep-22-25 06:15PM	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
09:05AM	PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes (GlobeNewswire)
Sep-19-25 12:03AM	3 Reasons PACB is Risky and 1 Stock to Buy Instead (StockStory)
Sep-15-25 11:46AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Sep-14-25 11:36PM	Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest (StockStory)
Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%
Aug-19-25 01:51PM	Cathie Woods ARK Innovation Sees Outflows, But Buys More Deere Stock Anyway (Barrons.com)
Aug-14-25 01:34AM	The Top 5 Analyst Questions From PacBio's Q2 Earnings Call (StockStory)
Aug-13-25 03:01PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +5.79%
Aug-11-25 09:38AM	PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results (StockStory) -6.67%
Aug-08-25 12:21PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +7.14%
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
Aug-07-25 07:30PM	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -8.70%
07:00PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:58PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
05:07PM	PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:05PM	PacBio Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-06-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-05-25 11:18PM	PacBio (PACB) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 09:15AM	Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:05AM	Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models (GlobeNewswire)
Jul-31-25 12:03AM	3 Reasons to Avoid PACB and 1 Stock to Buy Instead (StockStory) -7.38%
Jul-29-25 06:15PM	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -6.10%

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM

Open in Screener

MRNA

Moderna Inc

Feb 13 • 04:00PM ET

42.23

+2.12 5.29 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO VB RSP IVV SPY VBR XBI IBB XLV

Index	S&P 500	P/E	-	EPS (ttm)	-7.26	Insider Own	8.54%	Shs Outstand	390.73M	Perf Week	2.97%
Market Cap	16.50B	Forward P/E	-	EPS next Y	-4.73	Insider Trans	-0.07%	Shs Float	357.38M	Perf Month	4.07%
Enterprise Value	11.96B	PEG	-	EPS next Q	-2.04	Inst Own	73.70%	Short Float	20.01%	Perf Quarter	58.11%
Income	-2.82B	P/S	8.49	EPS this Y	7.97%	Inst Trans	-4.04%	Short Ratio	6.17	Perf Half Y	58.22%
Sales	1.94B	P/B	1.77	EPS next Y	29.20%	ROA	-21.31%	Short Interest	71.51M	Perf YTD	43.20%
Book/sh	23.86	P/C	2.85	EPS next 5Y	25.98%	ROE	-28.87%	52W High	55.20 -23.50%	Perf Year	32.30%
Cash/sh	14.84	P/FCF	-	EPS past 3/5Y	- -29.93%	ROIC	-28.47%	52W Low	22.28 89.54%	Perf 3Y	-75.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-53.32% 19.33%	Gross Margin	55.35%	Volatility	7.83% 7.70%	Perf 5Y	-77.02%
Dividend TTM	-	EV/Sales	6.15	EPS Y/Y TTM	-38.95%	Oper. Margin	-158.13%	ATR (14)	3.23	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	-39.93%	Profit Margin	-145.16%	RSI (14)	53.99	Recom	2.96
Dividend Gr. 3/5Y	- -	Current Ratio	3.29	EPS Q/Q	27.57%	SMA20	-4.14%	Beta	1.35	Target Price	39.68
Payout	-	Debt/Eq	0.15	Sales Q/Q	-29.81%	SMA50	14.93%	Rel Volume	1.41	Prev Close	40.11
Employees	5800	LT Debt/Eq	0.15	Earnings	Feb 13 BMO	SMA200	43.87%	Avg Volume	11.59M	Price	42.23
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.07% 6.75%	Trades		Volume	16,328,201	Change	5.29%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142

Show Previous Ratings

Feb-13-26 05:29PM	Analyst Report: Moderna, Inc. (Morningstar Research) +5.29%
05:12PM	Stocks to Watch Friday Recap: Applied Materials, Coinbase, DraftKings (The Wall Street Journal)
05:03PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:51PM	Moderna Is Losing Less Money Than Expected. The Stock Jumps After Earnings. (Barrons.com)
04:20PM	Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More Stock Market Movers (Barrons.com)
04:15PM	Loading…
04:15PM	Moderna, Inc. Q4 2025 Earnings Call Summary (Moby)
09:14AM	Moderna Pops On Fourth-Quarter Report, But Can It Overcome Recent FDA Setbacks? (Investor's Business Daily)
04:02PM	Stock market today: Dow, S&P 500, Nasdaq gains fizzle to cap week of sharp losses as AI fears grow (Yahoo Finance)
03:37PM	Stock market today: S&P 500, Dow, Nasdaq gains fizzle as CPI inflation cools, weekly losses loom (Yahoo Finance)
03:09PM	Stock market today: S&P 500, Dow, Nasdaq rise as CPI inflation cools, but weekly losses loom (Yahoo Finance)
02:51PM	These Stocks Are Todays Movers: Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More (Barrons.com)
02:16PM	Moderna Challenges FDA After Flu Shot Review Refusal, 26% Covid Drop (GuruFocus.com)
02:13PM	Stocks to Watch Friday: Applied Materials, Coinbase, DraftKings (The Wall Street Journal)
02:01PM	Moderna Inc (MRNA) Q4 2025 Earnings Call Highlights: Strategic Cost Reductions Amidst Financial ... (GuruFocus.com)
12:03PM	Moderna shares pop on strong guidance, smaller-than-expected loss (Proactive)
11:38AM	Loading…
11:38AM	Moderna Q4 Loss Narrower-Than-Expected, Sales Beat Estimates (Zacks)
11:17AM	CPI Increased in Line With Expectations (Zacks)
10:59AM	Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms (Benzinga)
10:49AM	MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell? (Zacks)
10:47AM	Rivian stock surges on EV delivery outlook, Pinterest plunges (Yahoo Finance Video)
10:35AM	Near-Perfect CPI Report Brings Pre-Markets Near Breakeven (Zacks)
10:27AM	Moderna Q4 Earnings Call Highlights (MarketBeat)
10:01AM	Softer-Than-Expected Inflation Sparks Rally In These 10 Stocks (Benzinga)
09:42AM	Stocks to Watch Friday: Applied Materials, Rivian, Coinbase, DraftKings (The Wall Street Journal)
09:03AM	Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls (The Wall Street Journal)
08:20AM	Moderna Just Crushed Estimates While Everyone Was Looking the Other Way (24/7 Wall St.)
08:20AM	Moderna (MRNA) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
07:56AM	Moderna Narrows Loss, Reiterates 10% Revenue Growth Target (The Wall Street Journal)
07:42AM	Moderna beats Q4 expectations, but stock edges lower on FDA setback (Investing.com)
07:29AM	Moderna Reports a Narrower-Than-Expected Loss. The Stock Slips After Earnings. (Barrons.com)
07:15AM	Loading…
07:15AM	Moderna: Q4 Earnings Snapshot (Associated Press Finance)
07:13AM	Moderna Reports a Narrower-Than-Expected Loss. The Stock Falls After Earnings. (Barrons.com)
07:12AM	Moderna beats quarterly revenue estimates on resilient sales of COVID shot (Reuters)
07:11AM	Moderna (NASDAQ:MRNA) Exceeds Q4 CY2025 Expectations (StockStory)
07:00AM	Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates (ACCESSWIRE)
05:54AM	These Stocks Are Today's Movers: Applied Materials, Arista, Coinbase, DraftKings, Expedia, Rivian, Roku, Pinterest, and More (Barrons.com)
Feb-12-26 07:55PM	Review & Preview: Another Rally Lost (Barrons.com)
07:00PM	January CPI, Moderna and Wendy's earnings: What to Watch (Yahoo Finance Video)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures slip as AI fears return ahead of CPI inflation update (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures flat as AI fears return ahead of CPI inflation report (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures falter after AI-stoked sell-off with CPI inflation on deck (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures fall after AI-stoked sell-off with CPI inflation on deck (Yahoo Finance)
06:48PM	Stock market today: Dow, S&P 500, Nasdaq futures climb as AI fears return ahead of CPI inflation report (Yahoo Finance)
12:40PM	Applied Materials Earnings, Inflation Data: Still to Come This Week (The Wall Street Journal)
10:46AM	Prasad overruled FDA scientists on Moderna application, STAT says (TipRanks)
08:11AM	Earnings live: Rivian stock surges on earnings beat, Pinterest plunges, Crocs soars (Yahoo Finance)
08:11AM	Earnings live: Cisco stock drops after outlook disappoints, AppLovin sinks, Equinix surges (Yahoo Finance)
07:27AM	Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader (24/7 Wall St.)
06:40AM	Company News for Feb 12, 2026 (Zacks)
03:09AM	CPI Data, Coinbase Earnings, Home Sales: Still to Come This Week (The Wall Street Journal)
Feb-11-26 10:01PM	What To Expect From Moderna's (MRNA) Q4 Earnings (StockStory)
09:23PM	Why the FDA Blocked Modernas New Flu Shot (The Wall Street Journal)
07:28PM	Analyst Report: Moderna, Inc. (Morningstar Research)
06:20PM	Stocks to Watch Wednesday Recap: Netflix, QXO, Moderna, SLB (The Wall Street Journal)
04:45PM	Earnings live: Cisco stock falls after outlook disappoints, McDonald's edges lower, Vertiv soars (Yahoo Finance)
04:36PM	Moderna Stock Sinks on Vaccine Rejection. Company Is Desperately Seeking Clarification. (Barrons.com)
04:36PM	Moderna Stock Sinks on Flu Vaccine Rejection. Company Is Desperately Seeking Clarification. (Barrons.com)
04:35PM	These Stocks Are Todays Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, Micron, and More (Barrons.com)
04:05PM	Moderna Plunges After FDA Rejects Its Messenger-RNA-Based Flu Shot (Investor's Business Daily)
03:13PM	Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves (Insider Monkey)
02:57PM	Dow still safely above 50,000 but early gains cut, Mattel and Lyft plunge (Proactive)
01:33PM	Mexico enlists Moderna to boost mRNA supply for respiratory diseases (Pharmaceutical Technology)
01:00PM	Moderna's investigational flu vaccine denied FDA review, shares drop (Proactive)
12:29PM	Why Moderna Stock Is Sinking Today (GuruFocus.com)
12:27PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:46AM	FDA declines to review Modernas seasonal flu mRNA vaccine (Pharmaceutical Technology)
10:45AM	MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA (Zacks)
10:44AM	Moderna's work developing seasonal vaccines is 'risky' under current FDA, analyst says (MarketWatch)
10:00AM	Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB (The Wall Street Journal)
09:44AM	Ancora to oppose WBD-Netflix deal, Kraft Heinz halts split plans (Yahoo Finance Video)
08:24AM	Moderna Stock Sinks. The Puzzling Reason Its Flu Vaccine Was Rejected. (Barrons.com)
08:11AM	Earnings live: Vertiv stock soars on upbeat outlook, Lyft and Robinhood shares tumble, Mattel plunges (Yahoo Finance)
07:05AM	Moderna Stock Sinks. The FDA Delivers a Blow to Its New Flu Vaccine. (Barrons.com)
06:44AM	Moderna shares fall as FDA declines to review new flu vaccine (Reuters)
06:18AM	Stocks Climb as January Jobs Growth Eases Economic Concerns (Barchart)
06:18AM	S&P Futures Tick Higher With All Eyes on Key U.S. Jobs Report (Barchart)
06:01AM	These Stocks Are Today's Movers: Moderna, Robinhood, Cloudflare, Lyft, Mattel, Beta Technologies, Gilead, and More (Barrons.com)
05:37AM	Moderna shares slide after FDA vaccine refusal, and other early market movers (MarketWatch)
05:21AM	FDA Refuses To Review Moderna's Influenza Shot Application (Benzinga)
04:33AM	Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill (BioPharma Dive)
03:38AM	Cisco Earnings, Jobs Report, CPI Data: Still to Come This Week (The Wall Street Journal)
01:49AM	FDA refuses to review Modernas mRNA flu vaccine (BioPharma Dive)
Feb-10-26 11:24PM	Wall Street rises to record levels after report showing the jobless rate improved last month (Associated Press Finance)
07:14PM	FDA Refuses to Consider Approving Use of Modernas New Flu Vaccine (The Wall Street Journal)
06:04PM	Moderna Takes It On The Chin After FDA Rejects Its Messenger-RNA-Based Flu Shot (Investor's Business Daily)
05:02PM	Earnings live: Lyft stock tanks on operating loss, Robinhood falls, Ford edges higher (Yahoo Finance)
05:02PM	Earnings live: Lyft stock tanks on operating loss, Mattel stock crashes, Robinhood falls, Ford rises (Yahoo Finance)
02:03PM	Rotation Lifts Energy 23% as Tech Slips Since Oct. 28 (GuruFocus.com)
12:26PM	Moderna, Mexico Partner To Boost Local Vaccine Production (Benzinga)
11:01AM	Jim Cramer on Moderna: "One of the Hottest Stocks in the Market This Year" (Insider Monkey)
10:45AM	Vertex Gears Up to Report Q4 Earnings: Is a Beat in the Cards? (Zacks)
08:15AM	Earnings live: Spotify stock jumps on subscriber growth, CVS earnings beat, BP halts stock buybacks (Yahoo Finance)
07:00AM	Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico (ACCESSWIRE)
06:41AM	What Does the Street Think About Moderna, Inc. (MRNA)? (Insider Monkey)
Feb-09-26 05:45PM	Moderna (MRNA) Laps the Stock Market: Here's Why (Zacks)
04:54PM	Earnings live: Kyndryl and Monday.com stocks tank, Cleveland-Cliffs slides, Chegg drops (Yahoo Finance)
04:08PM	Betting On Moderna? This New Defiance ETF Turns The Volume Up 2X (Benzinga)
01:28PM	Can This Former Pandemic Star Make a Stunning Comeback? (Barchart)
11:38AM	Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? (Zacks)
11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience